Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.
about
Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@ast
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@en
type
label
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@ast
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@en
prefLabel
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@ast
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@en
P2093
P2860
P921
P1476
Efficacy and Safety of Risedro ...... III Trials Conducted in Japan.
@en
P2093
Daisuke Inoue
Ryo Okazaki
Ryoichi Muraoka
Toshitsugu Sugimoto
Yoshiki Nishizawa
P2860
P2888
P304
P356
10.1007/S00223-015-0071-9
P407
P577
2015-10-14T00:00:00Z